---
title: "Aardvark Therapeutics (AARD.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/AARD.US/norm.md"
symbol: "AARD.US"
name: "Aardvark Therapeutics"
parent: "https://longbridge.com/en/quote/AARD.US.md"
datetime: "2026-03-03T19:37:05.926Z"
locales:
  - [en](https://longbridge.com/en/quote/AARD.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/AARD.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/AARD.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/AARD.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/AARD.US/norm.md)


# Aardvark Therapeutics (AARD.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.7514 | -0.6624 | -0.7056 | -2.16 | -1.05 |
| ROE | -50.34% | -39.96% | -77.55% | 69.66% | 37.81% |
| Revenue | - | - | - | - | - |
| Net income | -16.32M | -14.37M | -9.31M | -8.78M | -4.18M |
| Operating income | -17.70M | -15.85M | -10.47M | -9.45M | -5.09M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 133.23M | 147.47M | 157.03M | 77.51M | 83.74M |
| Leverage | 1.09 | 1.08 | 1.04 | 1.07 | 1.04 |
| BVPS | 5.63 | 6.31 | 6.95 | -13.44 | -11.38 |
| Turnover | - | - | - | - | - |
| Cash & STI | 126.35M | 141.82M | 151.26M | 73.66M | 82.36M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 439000.00 | 522000.00 | 628000.00 | 735000.00 | 841000.00 |
| Net debt | -125.81M | -141.18M | -150.53M | -72.88M | -81.49M |

## Cash Flow Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -16.13M | -9.84M | -11.39M | -7.73M | -3.96M |
| Investing CF | 29.25M | 9.41M | -112.62M | -11.89M | -5000.00 |
| Financing CF | 171000.00 | -71000.00 | 88.88M | -1.01M | 64000.00 |
| Free CF | -9.05M | -4.70M | -8.13M | -3.73M | -2.96M |
| OCF coverage | -403250.00% | -10817.58% | - | -128783.33% | -79100.00% |
| Repaid & issued | - | - | - | - | - |
| CapEx | -4000.00 | -91000.00 | - | -6000.00 | -5000.00 |